Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion type Assertion NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_head.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_provenance.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion evidence source_evidence_literature NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_provenance.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion SIO_000772 19015641 NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_provenance.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion wasDerivedFrom befree-20150227 NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_provenance.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion wasGeneratedBy ECO_0000203 NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_provenance.